SNGX logo

Soligenix (SNGX)

Profile

Full Name

Soligenix, Inc.

Ticker Symbol

SNGX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

April 4, 1994

Indexes

Not included

Website

http://www.soligenix.com

Employees

14

Key Details

Price

$2.07(+0.49%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$4.98(+60.66% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$2.07
SNGX price is $2.07

30-Day Relative Volume

0.66
SNGX 30-day relative volume is 0.66

Price Performance

Price Today change

+0.49%
SNGX price is up +0.49% today

Price YTD change

-23.33%
SNGX price is down -23.33% since January 1st

Price 1-year change

-74.63%
SNGX price is down -74.63% year-on-year

Price 3-year change

-98.82%
SNGX price is down -98.82% over the past 3 years

Price Range

Price All-time high

$3600000.00
SNGX price is currently -100.00% below its historical high of $3600000.00

Price 3-year low

$1.68
SNGX price is currently +23.21% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$6.53M
SNGX market capitalization is $6.53 million

Market cap 3-year change

-79.17%
SNGX market capitalization is down -79.17% over the past 3 years

Market cap All-time high

$324.00M
SNGX market capitalization is currently -97.98% below its historical high of $324.00 million

Market cap sector rank

15.87%
SNGX market capitalization is higher than 15.87% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+379.72%
SNGX shares outstanding is up +379.72% year-on-year

Shares Outstanding 3-Year Change

+1662.91%
SNGX shares outstanding is up +1662.91% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.76
SNGX beta is 0.76

200-day SMA

$3.32
SNGX price is currently -37.68% below its 200-day simple moving average

50-day SMA

$2.25
SNGX price is currently -7.81% below its 50-day simple moving average

RSI

46.78
SNGX 14-day relative strength index is 46.78

Volume

0.66
SNGX 30-day relative volume is 0.66

ATR

$0.19
SNGX average true range is $0.19

10-day Historical Volatility

124.31%
SNGX 10-day historical volatility is 124.31%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
SNGX annual revenue value is unknown

Revenue Analysts estimate

$1.00M
SNGX annual revenue is currently equal to the consensus analysts' forecast

Revenue 1-year change

-
SNGX annual revenue 1-year change is unknown

Revenue Sector rank

-
SNGX annual revenue is unknown

EPS

EPS

-$4.98
SNGX annual earnings per share is -$4.98

EPS Analysts estimate

-
SNGX annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+60.66%
SNGX annual earnings per share is up +60.66% year-on-year

EPS Sector rank

19.17%
SNGX annual earnings per share is higher than 19.17% of companies in Healthcare sector

Profit

Gross profit

-$119.40K
SNGX annual gross profit is -$119.40 thousand

Gross margin

-
SNGX annual gross profit margin value is unknown

Operating profit

-$9.46M
SNGX annual operating income is -$9.46 million

Operating margin

-
SNGX annual operating profit margin value is unknown

Net income

-$8.27M
SNGX annual net profit is -$8.27 million

Net margin

-
SNGX annual net profit margin value is unknown

Expenses

Total expenses

$9.46M
SNGX annual total expenses is $9.46 million

Operating expenses

$9.35M
SNGX annual total operating expenses is $9.35 million

Cost of goods sold

$119.40K
SNGX annual cost of goods sold is $119.40 thousand

Selling, general & administrative expenses

$4.22M
SNGX annual SGA is $4.22 million

Depreciation and amortization

$5800.00
SNGX annual depreciation & amortization is $5800.00

Interest expense

-
SNGX annual interest expense value is unknown

Income tax

-$409.10K
SNGX annual income tax is -$409.10 thousand

EBIT & EBITDA

EBIT

-$9.46M
SNGX annual earnings before interest & taxes is -$9.46 million

EBITDA

-$9.46M
SNGX annual EBITDA is -$9.46 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$8.97M
SNGX annual total assets is $8.97 million

Non current assets

$137.90K
SNGX annual long term assets is $137.90 thousand

Current assets

$8.83M
SNGX annual total current assets is $8.83 million

Cash and cash equivalents

$7.82M
SNGX annual cash & cash equivalents is $7.82 million

Accounts receivable

-
SNGX annual accounts receivable value is unknown

Inventory

-
SNGX annual inventory value is unknown

Liabilities

Total liabilities

$4.85M
SNGX annual total liabilities is $4.85 million

Long term liabilities

$0.00
SNGX annual total long term liabilities is $0.00

Current liabilities

$4.85M
SNGX annual total current liabilities is $4.85 million

Accounts payable

$667.90K
SNGX annual accounts payable is $667.90 thousand

Debt

Total debt

$1.48M
SNGX annual total debt is $1.48 million

Total debt 1-year change

-57.51%
SNGX annual total debt is down -57.51% year-on-year

Long term debt

$0.00
SNGX annual long term debt is $0.00

Short term debt

$1.48M
SNGX annual short term debt is $1.48 million

Equity & Capital

Shareholders equity

$4.12M
SNGX annual stockholders equity is $4.12 million

Book value

$4.12M
SNGX annual book value is $4.12 million

Retained earnings

-$233.97M
SNGX annual retained earnings is -$233.97 million

Working capital

$3.98M
SNGX annual working capital is $3.98 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$8.40M
SNGX annual cash flow from operations is -$8.40 million

Cash from operations 1-year change

+2.33%
SNGX annual cash flow from operations is up +2.33% year-on-year

Cash from investing

-
SNGX annual cash flow from investing activities value is unknown

Cash from investing 1-year change

-
SNGX annual cash flow from investing activities 1-year change is unknown

Cash from financing

$7.76M
SNGX annual cash flow from financing activities is $7.76 million

Cash from financing 1-year change

+111.88%
SNGX annual cash flow from financing activities is up +111.88% year-on-year

CAPEX

CAPEX

-
SNGX annual capital expenditures value is unknown

CAPEX 1-year change

-
SNGX annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$8.40M
SNGX annual free cash flow is -$8.40 million

Free cash flow 1-year change

+2.33%
SNGX annual free cash flow is up +2.33% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
SNGX annual gross profit margin value is unknown

Operating margin

-
SNGX annual operating profit margin value is unknown

Net margin

-
SNGX annual net profit margin value is unknown

ROA & ROE

ROA

-92.19%
SNGX annual return on assets is -92.19%

ROE

-200.74%
SNGX annual return on equity is -200.74%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
SNGX price to earnings ratio value is unknown

PE ratio Sector rank

-
SNGX price to earnings ratio is unknown

PB Ratio

PB ratio

1.59
SNGX price to book ratio is 1.59

PB ratio Sector rank

57.41%
SNGX price to book ratio is higher than 57.41% of companies in Healthcare sector

PS Ratio

PS ratio

-
SNGX price to sales ratio value is unknown

PS ratio Sector rank

-
SNGX price to sales ratio is unknown

Enterprise value

Enterprise value

$197.29K
SNGX enterprise value is $197.29 thousand

Enterprise value Sector rank

12.3%
SNGX enterprise value is higher than 12.3% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.02
SNGX EV/EBITDA is -0.02

EV/EBITDA Sector rank

64.17%
SNGX EV/EBITDA is higher than 64.17% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.82
SNGX annual current ratio is 1.82

Quick ratio

-
SNGX annual quick ratio value is unknown

Leverage

Debt to equity

0.36
SNGX annual debt to equity ratio is 0.36

Interest coverage ratio

-
SNGX annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
SNGX piotroski f-score value is unknown

Altman Z-Score

-
SNGX altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Dec 4, 20 B. Riley FBR
Buy
Jul 28, 20 Dawson James
Neutral
Jan 31, 18 H.C. Wainwright
Neutral
Aug 14, 17 Maxim Group
Buy
Jul 17, 17 H.C. Wainwright
Buy
Sep 7, 16 Aegis Capital
Buy

Institutional Ownership

Similar stocks

PTN logo
Palatin Technologies (PTN)
Apollomics (APLM)
PPBT logo
Purple Biotech (PPBT)
MetaVia (MTVA)
Mobile-health Network Solutions Class A (MNDR)
INBS logo
Intelligent Bio Solutions (INBS)
Silexion Therapeutics LTD (SLXN)
AYTU logo
Aytu BioPharma (AYTU)
SSY logo
SunLink Health Systems (SSY)
  • What is the ticker symbol for Soligenix?
  • Does Soligenix pay dividends?
  • What sector is Soligenix in?
  • What industry is Soligenix in?
  • What country is Soligenix based in?
  • When did Soligenix go public?
  • Is Soligenix in the S&P 500?
  • Is Soligenix in the NASDAQ 100?
  • Is Soligenix in the Dow Jones?
  • When was Soligenix's last earnings report?
  • When does Soligenix report earnings?
  • Should I buy Soligenix stock now?

What is the ticker symbol for Soligenix?

The ticker symbol for Soligenix is NASDAQ:SNGX

Does Soligenix pay dividends?

No, Soligenix does not pay dividends

What sector is Soligenix in?

Soligenix is in the Healthcare sector

What industry is Soligenix in?

Soligenix is in the Biotechnology industry

What country is Soligenix based in?

Soligenix is headquartered in United States

When did Soligenix go public?

Soligenix's initial public offering (IPO) was on April 4, 1994

Is Soligenix in the S&P 500?

No, Soligenix is not included in the S&P 500 index

Is Soligenix in the NASDAQ 100?

No, Soligenix is not included in the NASDAQ 100 index

Is Soligenix in the Dow Jones?

No, Soligenix is not included in the Dow Jones index

When was Soligenix's last earnings report?

Soligenix's most recent earnings report was on Nov 8, 2024

When does Soligenix report earnings?

The next expected earnings date for Soligenix is May 9, 2025

Should I buy Soligenix stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page